T. Rowe Price Investment Management, Inc. Iovance Biotherapeutics, Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $163 Billion
- Q1 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 1,313,339 shares of IOVA stock, worth $9.56 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,313,339Holding current value
$9.56 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding IOVA
# of Institutions
305Shares Held
221MCall Options Held
3.05MPut Options Held
1.6M-
Vanguard Group Inc Valley Forge, PA24.9MShares$181 Million0.01% of portfolio
-
Mhr Fund Management LLC New York, NY24MShares$175 Million40.86% of portfolio
-
Black Rock Inc. New York, NY19.9MShares$145 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY19.3MShares$140 Million5.99% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.7MShares$85.2 Million2.09% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $1.15B
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...